Magnitude Biosciences raises $1.6M
Magnitude Biosciences announced a Seed round of $1.6M on 15 September 2026. The company operates in HealthTech and is based in United Kingdom. It was founded by Fozia Saleem, CEO. Announced 43 days ago.
Founder
Fozia Saleem
CEO, Magnitude Biosciences
Outreach angles
- -Dr. Fozia Saleem leads Magnitude Biosciences, a Durham University spinout she built into a working contract research organisation.
- -She has positioned the company's VivoScan platform around whole-organism compound screening, a niche high-throughput drug discovery method.
- -The new funding, which includes an Innovate UK Investor Partnership grant, will accelerate commercialisation of VivoScan for drug discovery clients.
Signals
SeedHealthcareDeep TechB2BRevenue-Generating
Round details
Company: Magnitude Biosciences
Domain: magnitudebiosciences.com
Amount: $1.6M
Stage: Seed
Industry: HealthTech
Country: United Kingdom
Announced: 15 September 2026
Other HealthTech raises
Recently funded in United Kingdom